MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

(2015) Maria Carmela Speranza et al.   Oncotarget

Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines

(2012) Sunwoo Koo et al.   BMC CANCER

MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF

(2012) Chao Zou et al.   CELL CYCLE

The molecular mechanism of microRNA-145 to suppress invasion–metastasis cascade in gastric cancer

(2012) P Gao et al.   ONCOGENE

miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes

(2011) Harsh Dweep et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas

(2011) Lars Fischer et al.   NEURO-ONCOLOGY

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

(2011) Qing Xu et al.   NUCLEIC ACIDS RESEARCH

Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells

(2010) Liduan Zheng et al.   BMC CANCER

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene

(2010) Jianjun Zhang et al.   CANCER

Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility

(2010) Milena S. Nicoloso et al.   CANCER RESEARCH

MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis

(2010) Shih-Ting Cha et al.   CANCER RESEARCH

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

(2010) Masayuki Kano et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

(2010) Niamh H Foley et al.   Molecular Cancer

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

(2010) Li Ma et al.   NATURE CELL BIOLOGY

Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions

(2010) K S Chae et al.   ONCOGENE

miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

(2010) M Götte et al.   ONCOGENE

Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis

(2009) A. C. Aplin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

(2009) Greg M Arndt et al.   BMC CANCER

MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics

(2009) R. Stallings   CURRENT PHARMACEUTICAL DESIGN

Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia

(2009) R. Poincloux et al.   JOURNAL OF CELL SCIENCE

Tissue and Process Specific microRNA–mRNA Co-Expression in Mammalian Development and Malignancy

(2009) Hongye Liu et al.   PLoS One

Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration

(2009) Zhang Lei et al.   PLoS One

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HIF-2  maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells

(2009) A. Pietras et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression and clinical significance of heparanase in neuroblastoma

(2009) Li-Duan Zheng et al.   World Journal of Pediatrics

Functional genetic variation of human miRNAs and phenotypic consequences

(2008) Christelle Borel et al.   MAMMALIAN GENOME

The MYCN oncogene is a direct target of miR-34a

(2008) J S Wei et al.   ONCOGENE

Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM

(2008) Laura Fontana et al.   PLoS One